Table 3.
Cortical structure | Test 1, Multivariate Cox | Test 2, Wilcoxon Rank-Sum Test | Test 3, KM | ||||
---|---|---|---|---|---|---|---|
HR (CI: L, U) | p | Median OS (Low, High CT) days | W | p | Chi2 | p | |
Hemispheric CT | 0.09(0.02, 0.44) | .003* | 311,525 | 2120 | .0001* | 13.42 | .0003* |
Lobar CT | |||||||
Frontal | 0.20(0.05 0.71) | .013 | 314,525 | 2221 | .0004* | 10.7 | .001* |
Parietal | 0.11(0.03, 0.46) | .003* | 289,527 | 1879 | 2.7E−5* | 21.3 | 3.9E−6* |
Temporal | 0.14(0.04, 0.50) | .003* | 311,527 | 2078 | 5.6E−5* | 10.1 | .002* |
Parcel CT | |||||||
Fusiform | 0.15(0.05, 0.48) | .0007* | 334,525 | 2163 | .0002* | 12.23 | .0005* |
Inferior parietal | 0.17(0.05, 0.56) | .004 | 321,508 | 2284 | .0008* | 10.50 | .0012* |
Lateral orbitofrontal | 0.24(0.08, 0.75) | .014 | 324,530 | 2221 | .0004* | 9.43 | .0021 |
Paracentral | 0.32(0.14, 0.75) | .008 | 324,480 | 2171 | .0002* | 13.57 | .0002* |
Parsopercularis | 0.23(0.08, 0.63) | .005 | 312,522 | 2259 | .0006* | 9.21 | .0024 |
Precuneus | 0.26(0.09, 0.73) | .010 | 314,530 | 1970 | 1.1E−5* | 18.81 | 1.4E−5* |
Rostral middlefrontal | 0.27(0.10, 0.73) | .010 | 312,525 | 2148 | .0002* | 16.5 | 4.8E−5* |
Superior frontal | 0.28 (0.09, 0.82) | .020 | 334,491 | 2367 | .0002* | 9.16 | .002 |
Superior-parietal | 0.34 (0.13, 0.88) | .011 | 334,472 | 2344 | .0018 | 10.83 | .0009* |
Superior temporal | 0.34 (0.13, 0.88) | .026 | 314,525 | 2188 | .0002* | 14.38 | .0001* |
Supramarginal | 0.26 (0.08, 0.83) | .022 | 314,472 | 2250 | .00057* | 10.39 | .0013* |
Abbreviations: CT, cortical thickness; HR, hazard ratio; OS, overall survival.
Test 1: Multivariate Cox proportional hazards model was performed (with age, sex and hemisphere). Test 2: Wilcoxon rank-sum test of median overall survival of low versus high cortical thickness patients (WRS). Test 3: Kaplan–Meier test of survival difference (KM; *p < .05, Bonferroni correction).